Severn Biotech
Private Company
Funding information not available
Overview
Severn Biotech is a long-established, privately-held British manufacturer operating in the diagnostics and antibodies sectors. With over 36 years of operation, it has evolved from producing oligonucleotide probes to a broad portfolio of over 400 laboratory reagents, emphasizing peptide chemistry and custom conjugates for immunology. The company is ISO 9001:2015 certified and is implementing ISO 13485:2016 standards, supported by a new ISO 8 cleanroom facility, indicating a strategic focus on regulated diagnostic manufacturing. Its business model is service and product-based, catering to OEM and branded product needs for research and diagnostic applications.
Technology Platform
Expertise in peptide synthesis, oligonucleotide production, and bioconjugation chemistry for creating immunological reagents and custom biochemicals. Supported by ISO-compliant formulation and manufacturing capabilities, including a new ISO 8 cleanroom.
Opportunities
Risk Factors
Competitive Landscape
Severn Biotech competes in a fragmented market against large multinational life science suppliers (e.g., Thermo Fisher, Merck) and numerous specialized peptide synthesis and custom reagent companies. Its differentiation lies in being an independent, UK-based manufacturer with strong peptide chemistry expertise, ISO 9001 quality, and a focus on flexible, bespoke OEM services for the European market.